San Antonio Breast Cancer Symposium

Take a look back at #SABCS24! Thank you to the co-directors, executive committee, program planning committee, speakers, and attendees for making this year's symposium a tremendous success.

@uthealthsamda.bsky.social @theaacr.bsky.social

@vkaklamani.bsky.social talking with advocates in the “Hot Topics” session at @sabcs.bsky.social

SABCS Spotlight - YouTube The SABCS Spotlight series includes conversations with scientists, clinicians, survivors, advocates, and other thought leaders who share their experiences wi...

The #SABCS24 Spotlight series features conversations with scientists, clinicians, survivors, and advocates sharing their experiences from @sabcs.bsky.social the world's most comprehensive meeting on breast cancer research and treatment. www.youtube.com/playlist?lis...

Advocacy makes a difference 🎉
A week ago I shared w/ Dr. Alistair Thompson that "right-sizing treatment" is preferred terminology to "de-escalation." Latter can imply 'less than" which, in absence of strong health/disease literacy, can be terrifying.
Today he shared that info his #SABCS24 preso

Ian Kunkler presenting on the SUPRIMO Trial at @sabcs.bsky.social

@theaacr.bsky.social @uthealthsamda.bsky.social

Today’s #SABCS24 press conference featured tamoxifen for patients who forgo radiation after DCIS surgery, active monitoring in DCIS, chest wall irradiation after mastectomy, and adding palbociclib for HER2-positive breast cancer: www.aacr.org/about-the-aa...

Dr. Erika Mayer of @dfcibreastonc.bsky.social answering questions following her presentation about CDK4-6 inhibitors to patient advocates. Carrie Treadwell of @theaacr.bsky.social is moderating. @sabcs.bsky.social

Join our collaborators at @vjoncology.bsky.social during #SABCS24 , as they bring you the latest trial data and expert insights on breast cancer. Stay tuned for our comprehensive coverage of the event!

https://bit.ly/48P9tCd

#SABCS24 Preview: Nobel Laureate William G. Kaelin, Jr., MD, will deliver the keynote address at 8:35 am CT this morning. Learn more in SABCS Meeting News: www.sabcsmeetingnews.org/nobel-prize-...

#SABCS24 Day 1 Highlights #CommunityOnc:

1. @FDAOncology Reviews recent approvals: #Ribociclib & #Inavolisib

2. #PADMA: HR+ ET + CDK4/6i vs Chemo 1L

3. #DB06: HR+ TDXd

4. #KN522: biomarker analysis

#OncSky #CanSky @sabcs.bsky.social @drsarahsammons.bsky.social @dr-rshatsky.bsky.social

1/5

Padma trial confirms that no role of chemo in first line chemo in HR+ HER2- MBC. Great data. #sabcs24. @sabcs.bsky.social

The 2024 San Antonio Breast Cancer Symposium begins this afternoon. The photo shows the entrance to the Henry B. Gonzalez Convention Center in San Antonio, Texas. #SABCS24

The San Antonio Breast Cancer Symposium will begin this afternoon with Concurrent Special Sessions on new drug approvals, risk reduction and early detection, and lifestyle factors and cancer. #SABCS24 @theaacr.bsky.social @uthealthsamda.bsky.social

Safe travels! See you in San Antonio. #SABCS24

Onsite registration for #SABCS24 is now open! We look forward to seeing everyone tomorrow starting at 12:00 noon CT.
@theaacr.bsky.social @uthealthsamda.bsky.social

Safe travels! See you in San Antonio. #SABCS24

Have a safe flight to San Antonio. #SABCS24

Safe travels! See you in San Antonio. #SABCS24

We are looking forward to this year's San Antonio Breast Cancer Symposium which starts on December 10. Take a look at the full program for this important meeting featuring the latest research on breast cancer. sabcs.org/FullProgram #SABCS24 #breastcancer